Using both nasal and conjunctival sample types, Alveo's point of care, cloud-connected molecular testing solution detects and differentiates between Influenzas A, B and A(H5) in humans ALAMEDA, Calif.
The Centers for Disease Control and Prevention and the Georgia Institute of Technology in Atlanta are working together to develop a microneedle patch that could make it easier to vaccinate people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback